AVAS 2019 Session IV

1. The most common primary malignancy of liver is

Hepatoblastoma

Hemangiosarcoma

Hepatocellular carcinoma

Cholangiocarcinoma

About This Quiz

AVAS Session IV, Tuesday April 30, 2019

2. What's your name?

We’ll put your name on your report, certificate, and leaderboard.

2. A 58yo man presents with hypertrophic cardiomyopathy and midventricular obstruction. What is the appropriate treatment?

The classic Morrow septal myectomy

The modified Morrow septal myectomy

Medicine

Others

3. The main outcome studied on presentation "VOLUME TO OUTCOME RELATIONSHIP IN VALVULAR PROCEDURES: ANNUAL VOLUME OR CUMULATIVE VOLUME?" was:

ICU days

Mortality

Ventilator days

Total length of stayB

4. A 66yo man with coronary artery disease is now status post CABG. Effective revascularization documented at 1-year post-CABG angiography is associated with:

Lower 1 to 5-year post-CABG mortality

Lower 1 to 5-year post-CABG MACE

More repeat revascularizations from year 1 to 5 years post-CABG

Lower 1 to 10-year post-CABG mortality

5. What is the SYNTAX score?

Index of anatomical complexity of coronary disease

TEE classification scheme

Risk assessment score for 30-day mortality

European risk score

6. A 70yo man with a long history of smoking presents with shortness of breath and is found to have a new left lower lobe mass as well as a large left pleural effusion. Which of the following statement is true regarding malignant pleural effusions?

Malignant pleural effusions tend to be void of immune cells.

Adoptive T cell transfer utilizes T cells from a mouse to combat cancer in a human.